166 related articles for article (PubMed ID: 38216936)
21. Capsular extension at ultrasound is associated with lateral lymph node metastasis in patients with papillary thyroid carcinoma: a retrospective study.
Ye L; Hu L; Liu W; Luo Y; Li Z; Ding Z; Hu C; Wang L; Zhu Y; Liu L; Ma X; Kong Y; Huang L
BMC Cancer; 2021 Nov; 21(1):1250. PubMed ID: 34800991
[TBL] [Abstract][Full Text] [Related]
22. The synergic effect of BRAF
Qu HJ; Qu XY; Hu Z; Lin Y; Wang JR; Zheng CF; Tan Z
Endocr J; 2018 Jan; 65(1):113-120. PubMed ID: 29070763
[TBL] [Abstract][Full Text] [Related]
23. Significance of distance between tumor and thyroid capsule as an indicator for central lymph node metastasis in clinically node negative papillary thyroid carcinoma patients.
Seong CY; Chai YJ; Lee SM; Kim SJ; Choi JY; Lee KE; Hwang KT; Park SW; Yi KH
PLoS One; 2018; 13(7):e0200166. PubMed ID: 30016353
[TBL] [Abstract][Full Text] [Related]
24. Significance of multifocality in papillary thyroid carcinoma.
Feng JW; Qu Z; Qin AC; Pan H; Ye J; Jiang Y
Eur J Surg Oncol; 2020 Oct; 46(10 Pt A):1820-1828. PubMed ID: 32732090
[TBL] [Abstract][Full Text] [Related]
25. High-risk factors for lymph node metastasis in contralateral central compartment in unilateral papillary thyroid carcinoma（cT1N0）.
Zhou B; Qin J
Eur J Surg Oncol; 2021 Apr; 47(4):882-887. PubMed ID: 33092967
[TBL] [Abstract][Full Text] [Related]
26. Predicting skip metastasis in lateral lymph nodes of papillary thyroid carcinoma based on clinical and ultrasound features.
Zhao M; Shi X; Zou Z; Wen R; Lu Y; Li J; Cao J; Zhang B
Front Endocrinol (Lausanne); 2023; 14():1151505. PubMed ID: 37229457
[TBL] [Abstract][Full Text] [Related]
27. Radiomics analysis of dual-energy CT-derived iodine maps for diagnosing metastatic cervical lymph nodes in patients with papillary thyroid cancer.
Zhou Y; Su GY; Hu H; Ge YQ; Si Y; Shen MP; Xu XQ; Wu FY
Eur Radiol; 2020 Nov; 30(11):6251-6262. PubMed ID: 32500193
[TBL] [Abstract][Full Text] [Related]
28. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
[TBL] [Abstract][Full Text] [Related]
29. Nomograms based on preoperative multimodal ultrasound of papillary thyroid carcinoma for predicting central lymph node metastasis.
Dai Q; Liu D; Tao Y; Ding C; Li S; Zhao C; Wang Z; Tao Y; Tian J; Leng X
Eur Radiol; 2022 Jul; 32(7):4596-4608. PubMed ID: 35226156
[TBL] [Abstract][Full Text] [Related]
30. Risks of central lymph node metastasis in papillary thyroid carcinoma with or without multifocality in at least one lobe: A multi-center analysis.
Heng Y; Yang Z; Lin J; Liu Q; Cai W; Tao L
Oral Oncol; 2022 Nov; 134():106185. PubMed ID: 36191477
[TBL] [Abstract][Full Text] [Related]
31. Deep learning-based multifeature integration robustly predicts central lymph node metastasis in papillary thyroid cancer.
Wang Z; Qu L; Chen Q; Zhou Y; Duan H; Li B; Weng Y; Su J; Yi W
BMC Cancer; 2023 Feb; 23(1):128. PubMed ID: 36750791
[TBL] [Abstract][Full Text] [Related]
32. Machine Learning Algorithms for the Prediction of Central Lymph Node Metastasis in Patients With Papillary Thyroid Cancer.
Wu Y; Rao K; Liu J; Han C; Gong L; Chong Y; Liu Z; Xu X
Front Endocrinol (Lausanne); 2020; 11():577537. PubMed ID: 33193092
[TBL] [Abstract][Full Text] [Related]
33. Nomogram Based on Shear-Wave Elastography Radiomics Can Improve Preoperative Cervical Lymph Node Staging for Papillary Thyroid Carcinoma.
Jiang M; Li C; Tang S; Lv W; Yi A; Wang B; Yu S; Cui X; Dietrich CF
Thyroid; 2020 Jun; 30(6):885-897. PubMed ID: 32027225
[No Abstract] [Full Text] [Related]
34. Ultrasound-based radiomics analysis for preoperative prediction of central and lateral cervical lymph node metastasis in papillary thyroid carcinoma: a multi-institutional study.
Tong Y; Zhang J; Wei Y; Yu J; Zhan W; Xia H; Zhou S; Wang Y; Chang C
BMC Med Imaging; 2022 May; 22(1):82. PubMed ID: 35501717
[TBL] [Abstract][Full Text] [Related]
35. Clinical features and imaging examination assessment of cervical lymph nodes for thyroid carcinoma.
Wei B; Yao J; Peng C; Zhao S; Wang H; Wang L; Zhu X; Kong Y; Chen L; Xu D
BMC Cancer; 2023 Dec; 23(1):1225. PubMed ID: 38087256
[TBL] [Abstract][Full Text] [Related]
36. [Application of Ultrasound Model for Predicting Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma].
Tian X; Luo Y; Zhang Y; Song Q; Ren L; Zhang Y; Jiang B
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Oct; 42(5):626-631. PubMed ID: 33131517
[TBL] [Abstract][Full Text] [Related]
37. A novel approach to quantify calcifications of thyroid nodules in US images based on deep learning: predicting the risk of cervical lymph node metastasis in papillary thyroid cancer patients.
Wang J; Dong C; Zhang YZ; Wang L; Yuan X; He M; Xu S; Zhou Q; Jiang J
Eur Radiol; 2023 Dec; 33(12):9347-9356. PubMed ID: 37436509
[TBL] [Abstract][Full Text] [Related]
38. Clinical risk factors for central lymph node metastasis in papillary thyroid carcinoma: a systematic review and meta-analysis.
Qu H; Sun GR; Liu Y; He QS
Clin Endocrinol (Oxf); 2015 Jul; 83(1):124-32. PubMed ID: 25130203
[TBL] [Abstract][Full Text] [Related]
39. Risk prediction for central lymph node metastasis in isolated isthmic papillary thyroid carcinoma by nomogram: A retrospective study from 2010 to 2021.
Zhao Y; Shi W; Dong F; Wang X; Lu C; Liu C
Front Endocrinol (Lausanne); 2022; 13():1098204. PubMed ID: 36733797
[TBL] [Abstract][Full Text] [Related]
40. The Value of Ki-67 Labeling Index in Central Lymph Node Metastasis and Survival of Papillary Thyroid Carcinoma: Evidence From the Clinical and Molecular Analyses.
Lei Y; Zhao X; Feng Y; He D; Hu D; Min Y
Cancer Control; 2023; 30():10732748231155701. PubMed ID: 36744396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
